Skip to main content
Realcan Pharmaceutical Group Co.,Ltd. logo

Realcan Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 002589 ISIN · CNE1000013X5 LEI · 300300YI5IV3FBRRSJ48 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,678 across all filing types
Latest filing 2017-08-17 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002589

About Realcan Pharmaceutical Group Co.,Ltd.

https://www.realcan.cn

Realcan Pharmaceutical Group Co., Ltd. specializes in the distribution of pharmaceutical products, medical devices, and healthcare consumables. The company operates an extensive supply chain network, providing integrated logistics and distribution services primarily to medical institutions and healthcare providers. Its core operations include the procurement, storage, and delivery of a wide range of medical supplies, supported by advanced information management systems and cold-chain logistics capabilities. Realcan also offers value-added services such as hospital supply chain optimization, third-party logistics, and financial solutions tailored to the healthcare industry. By focusing on a direct-to-hospital distribution model, the company aims to enhance the efficiency of medical supply procurement and ensure the timely delivery of critical healthcare products.

Recent filings

Filing Released Lang Actions
2017年第二次临时股东大会的律师见证法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2017 second extraordinary shareholders' meeting of Ruikang Pharmaceutical Co., Ltd. It details the legal verification of the meeting's convening, attendance, agenda, voting procedures, and results. The document does not contain financial statements or performance data but focuses on the legality and procedural correctness of the shareholders' meeting and its resolutions. It is not an announcement of voting results per se, but a legal opinion on the meeting and its resolutions. This type of document fits best under Regulatory Filings (RNS) as it is a legal compliance document related to corporate governance and shareholder meetings, not a direct report like AGM materials or voting results announcements.
2017-08-17 Chinese
2017年第二次临时股东大会决议的公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of the resolutions passed at the 2017 second extraordinary general meeting of shareholders of 瑞康医药股份有限公司. It details the meeting date, attendance, voting results on specific proposals, and legal opinions confirming the validity of the meeting and votes. The document does not contain financial statements or detailed financial analysis but reports the official voting results of shareholder decisions. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (1740 characters), consistent with a voting results announcement rather than a full report or presentation.
2017-08-17 Chinese
第三届董事会第七次会议决议的公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the company's third board of directors' seventh meeting. It details decisions made by the board regarding financing proposals and the scheduling of a shareholders' meeting. The text includes voting results and references to other announcements for further details. It does not contain financial statements or detailed financial data itself, but rather reports on board decisions and meeting outcomes. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors. The document length is short (2185 characters), and it is not a report or presentation but a meeting resolution announcement.
2017-08-01 Chinese
关于转让公司及下属子公司部分应收账款发行资产支持证券的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's plan to issue asset-backed securities by transferring certain accounts receivable to a special asset management plan. It details the transaction overview, parties involved, transaction assets, agreements, and the purpose and impact on the company. The document is relatively short (1427 characters) and serves as a formal public announcement of a financing transaction rather than a full financial report or detailed financial data. It does not contain financial statements or comprehensive financial analysis. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2017-08-01 Chinese
关于转让公司及下属子公司部分应收账款发行资产支持票据的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's plan to issue asset-backed notes by transferring certain accounts receivable to a trust company. It details the transaction overview, parties involved, transaction assets, agreements, and the intended impact on the company. There is no financial statement or detailed financial report included. The document is relatively short (1649 characters) and serves as a formal announcement of a capital/financing activity rather than a full report or regulatory filing. Therefore, it fits best under Capital/Financing Update (CAP).
2017-08-01 Chinese
关于召开2017年第二次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a notice about convening the 2017 second extraordinary general meeting of shareholders for 瑞康医药股份有限公司. It details the meeting time, location, voting procedures, eligibility, agenda items, and proxy authorization. It does not contain financial statements or results but is an announcement informing shareholders about the meeting and how to participate and vote. The document length is 4285 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, it is not an Annual Report, Interim Report, or Earnings Release. It is not a Declaration of Voting Results since it precedes the meeting. It is not a Proxy Solicitation document because it does not solicit votes but informs about the meeting. The best fitting category is AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or notices about such meetings.
2017-08-01 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.